TABLE 2

Demographics and Clinical Patient Data

Patient no.	Sex	Age (y)	Diagnosis	Treated knee	Surgery	Medication	C-reactive protein (mg/dL) T₀	Clinical score			Patient’s satisfaction
Patient no.	Sex	Age (y)	Diagnosis	Treated knee	Surgery	Medication	C-reactive protein (mg/dL) T₀				Patient’s satisfaction	T₀	T₁
1	F	30	PA	L	Nil	NSAR, MTX	0.8	6	4	2
2*	F	42	RA	L	BCR	NSAR, SP, GC	5.1	6	1	2
3	F	34	RA	R	BCR	NSAR, MTX	4.6	6	1	3
4*	M	34	VNS	R	2× SE	Nil	0.5	8	0	3
5	F	41	PA	R	SE	NSAR, MTX, GC	6.8	6	2	3
6	M	29	RA	R	SE	NSAR	0.5	7	3	1
7	F	76	RA	R	BCR	NSAR, MTX, GC	1.1	6	2	3
8	F	54	VNS	R	SE	Nil	0.5	4	0	3
9	F	42	RA	R	SE	NSAR, L, GC	0.5	8	2	1
10	M	51	PA	R	SE	NSAR, MTX, GC	0.8	7	3	2
11	F	26	VNS	R	SE	Nil	0.5	6	4	2
12	M	31	VNS	L	SE	NSAR	0.7	6	0	2
13	M	33	SA	L	SE	Nil	1	3	0	3
14	F	74	RA	L	BCR	NSAR, MTX	1.5	7	n.a.	n.a.
15	M	28	SA	R	SE	NSAR	1	5	2	1
16	F	41	PA	L	SE	NSAR, MTX	6	6	2	1
17	M	54	RA	L	SE	NSAR, GC	8.9	6	5	2
18	M	63	VNS	L	SE	Nil	0.5	9	0	1
19	F	31	RA	R	SE	GC, SP	1.9	6	0	1
20	F	70	RA	L	SE	NSAR, GC, L	3.4	5	3	2
21	M	41	PA	R	SE	NSAR, GC	0.5	4	n.a.	n.a.
22	M	57	RA	L	SE	NSAR, GC	2.5	9	n.a.	n.a.
23	M	37	SA	R	SE	NSAR	0.5	4	0	1
24	M	34	PA	R	SE	NSAR	0.5	7	2	1

↵* Both knee joints were treated.
T₀ = before radiation synovectomy; T₁ = 1 y after RS; PA = psoriatic arthritis; NSAR = nonsteroidal antirheumatics; MTX = methotrexate; RA = rheumatoid arthritis; BCR = Baker’s cyst resection; SP = salazopyrine; GC = glucocorticoids; VNS = villonodular synovitis; SE = synovectomy; L = leflunomide; SA = seronegative arthritis; n.a. = not available.